How does startup series funding work?

Series funding, in plain English

Startup series funding is a step-by-step way of financing a company by raising multiple rounds of capital over time. In each round you typically sell equity (ownership shares) to investors in exchange for cash to hit the next set of milestones.

Think of it like clinical trial phases: each phase has a different goal, a different level of evidence expected, and a different budget. Investors are buying the right to participate in your upside, but they also want risk reduced at each stage.

Most venture-backed companies follow a rough sequence:

• Pre-seed (optional label): prove the problem and early solution
• Seed: prove you can build and sell a repeatable product
• Series A: prove a scalable growth engine
• Series B: scale teams and revenue efficiently
• Series C+: expand, acquire, or push toward IPO/large exit

Not every startup needs every round. Some bootstrap (self-fund), some raise only seed, and some raise many rounds depending on capital intensity and growth.

What each round is for (and what investors expect)

Rounds are less about a calendar date and more about risk reduction. Each “series” is a new bet with new expectations.

Pre-seed: validate the wedge

Goal: show there’s a real problem and you have a credible approach. Typical evidence includes strong founder-market fit (you understand the domain), early prototypes, design partners, or early usage.

Common use of funds: building an MVP (minimum viable product), early customer discovery, and initial hiring (often 1–3 key roles).

Seed: prove repeatability

Goal: demonstrate you can consistently acquire customers and deliver value. Investors look for early traction signals: pilots converting to paid, retention, usage growth, or clear willingness to pay.

Common use of funds: shipping product, tightening onboarding, early go-to-market (sales/marketing), and building a small team.

Series A: build a scalable machine

Goal: show a repeatable go-to-market motion that can scale. “Go-to-market” (GTM) means how you acquire, convert, and retain customers (sales, marketing, partnerships, pricing, onboarding).

Investors want evidence that unit economics can work at scale. Unit economics means the profit math per customer: how much it costs to acquire and serve them versus how much you earn over time.

Series B: scale efficiently

Goal: expand the growth engine and organization. This is where hiring ramps: sales teams, customer success, product org, and management layers. Investors scrutinize efficiency: growth rate relative to burn (spend).

Series C and beyond: expansion and optionality

Goal: enter new markets, launch new product lines, make acquisitions, or position for IPO/strategic sale. Later rounds often include more complex investor mixes (growth equity, crossover funds) and heavier focus on predictability.

The mechanics: valuation, dilution, and how a round is priced

In an equity round you negotiate two big things:

• How much money you raise (the check size)
• At what valuation (what the company is “worth” for this deal)

Two valuation terms matter:

• Pre-money valuation: value before the new money comes in
• Post-money valuation: value after the new money comes in (pre-money + new investment)

Dilution is the percentage of the company you give up. A simple approximation:

Investor ownership % ≈ investment / post-money valuation

Example: you raise $5M at a $20M pre-money valuation. Post-money is $25M. New investors own about 20% ($5M/$25M). Founders and existing shareholders collectively go from 100% to ~80% (before considering option pool changes).

Option pool: the “hidden” dilution lever

Most priced rounds require an option pool (shares reserved for future employees). Investors often ask that the pool be created or “topped up” before the round closes, which effectively dilutes founders more than the headline investor percentage.

Practical takeaway: when you hear “we’re only selling 20%,” ask: “Is that including the option pool increase?”

Instruments: priced equity vs SAFE/convertible notes

Early rounds often use simpler instruments:

• SAFE (Simple Agreement for Future Equity): money now, converts into equity later. Usually includes a valuation cap (max conversion valuation) and/or a discount (e.g., 10–20%) to reward early risk.
• Convertible note: like a loan that converts to equity later; includes interest and a maturity date. Similar economics to a SAFE but with debt-like features.
• Priced round: you set a valuation now and issue preferred shares. More legal work, but clearer ownership.

SAFEs/notes delay the valuation debate, which can be helpful pre-seed/seed. But they stack up: too many uncapped or high-cap SAFEs can create a messy cap table (ownership spreadsheet) and surprise dilution at Series A.

Key terms you’ll see in Series A/B term sheets

A term sheet is the high-level deal document that outlines economics and control before the long legal docs. You don’t need an MBA to negotiate, but you do need to know what moves the outcome.

• Preferred stock: investors get preferred shares with special rights (common in venture rounds).
• Liquidation preference: who gets paid first in an exit. A common structure is “1x non-participating,” meaning investors get their money back first (up to 1x), then everyone shares the rest pro-rata. More aggressive structures exist; understand them before signing.
• Pro-rata rights: investors can maintain their ownership in future rounds by investing again.
• Board composition: who controls the board seats. Control matters more than most first-time founders expect.
• Protective provisions: actions that require investor approval (e.g., issuing new shares, selling the company).
• Anti-dilution: protections if a future round is at a lower valuation (a “down round”). The details can be founder-friendly or painful.

If you’re a technical/medical founder, treat these like system constraints: small wording differences can change outcomes dramatically. Get a startup-experienced lawyer for priced rounds.

How investors decide “you’re ready” for the next series

Investors fund the next round when they believe: (1) the risk is reduced enough, and (2) the new capital can produce a step-change in value before you run out of cash.

Most rounds are justified by a milestone plan tied to a runway target. “Runway” is how long until you hit $0 cash at your current burn rate. Many founders aim to raise enough for roughly 18–24 months of runway, but it varies with growth rate and market conditions.

What “ready” often looks like by stage:

• Seed: clear ICP (ideal customer profile), early repeatable sales, retention/usage signals
• Series A: predictable pipeline, improving unit economics, strong retention, a GTM motion that scales beyond founder-led sales
• Series B: multiple reps hitting quota, strong net revenue retention (for SaaS), efficient growth, mature reporting

Even if you’re not SaaS, the pattern holds: investors want evidence your growth is not a one-off and that your team can operationalize it.

What to do next

1. Map your next 18 months: write a milestone plan with 3–5 measurable targets (product, traction, hiring) and the budget needed to hit them.
2. Model dilution scenarios: build a simple cap table with at least three cases (conservative/base/aggressive) including option pool increases and SAFE conversions.
3. Draft your fundraising narrative: one page that states the problem, your wedge, why now, traction, and what this round unlocks.
4. Pressure-test your terms: run a mock term sheet review and list your “must-haves” (e.g., board control, liquidation preference limits).
5. Get structured help: use /finances to sanity-check runway and dilution, and /launchpad to plan milestones and fundraising materials.